Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

ClinicalTrials.gov ID: NCT04968912

Public ClinicalTrials.gov record NCT04968912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of nipocalimab in participants with primary Sjogren's syndrome (pSS) versus placebo.

Study identification

NCT ID
NCT04968912
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
163 participants

Conditions and interventions

Interventions

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2021 (Actual)
Primary completion
Oct 23, 2023 (Actual)
Completion
Nov 30, 2023 (Actual)
Last update posted
Nov 5, 2025

2021 – 2023

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Anniston Medical Clinic Anniston Alabama 36207 —
Arizona Arthritis and Rheumatology Research PLLC Glendale Arizona 85306 —
Arizona Arthritis & Rheumatology Research, PLLC Mesa Arizona 85210 —
St. Jude Heritage Medical Group Fullerton California 92835 —
Inland Rheumatology Clinical Trials, Inc. Upland California 91786 —
Colorado Arthritis Associates Denver Colorado 80228 —
Denver Arthritis Clinic Denver Colorado 80230 —
Rheumatology Associates Of South Florida Boca Raton Florida 33486 —
Bay Area Arthritis and Osteoporosis Brandon Florida 33511 —
Centre for Rheumatology, Immunology and Arthritis Fort Lauderdale Florida 33309 —
University of Florida Health Jacksonville Jacksonville Florida 32209 —
Omega Research Consultants Orlando Florida 32835 —
Clinical Investigation Specialists Gurnee Illinois 60031 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
St. Paul Rheumatology P A Eagan Minnesota 55121 —
North Mississippi Medical Clinics Tupelo Mississippi 38801 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Columbia Arthritis Center Columbia South Carolina 29204 —
West Tennessee Research Institute Jackson Tennessee 38305 —
Dr. Ramesh Gupta Memphis Tennessee 38119 —
Austin Regional Clinic Austin Texas 78731-3146 —
Trinity Clinical Research, LLC Carrollton Texas 75007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04968912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04968912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →